TY - JOUR T1 - Treating mild gestational diabetes yields benefits with little or no evidence of harms JF - Evidence Based Medicine JO - Evid Based Med SP - 88 LP - 88 DO - 10.1136/eb-2013-101520 VL - 19 IS - 3 AU - Donald Coustan Y1 - 2014/06/01 UR - http://ebm.bmj.com/content/19/3/88.abstract N2 - Commentary on: Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013;159:123–9.OpenUrlCrossRefPubMedWeb of Science The screening, diagnosis and treatment of gestational diabetes have been a contentious topic for at least 25 years, when Hunter and Keirse1 concluded, “Except for research purposes, all forms of glucose tolerance testing should be stopped.” This judgement was based on a lack of firm epidemiological evidence for benefit to the population, and the need for “population-based research to establish the true risk of sub-diabetic degrees of hyperglycaemia during pregnancy,” which should then be followed by ‘rigorous, randomized trials’ of therapy. In recent years the HAPO study established a continuum of adverse pregnancy outcomes associated with increasing maternal … ER -